This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Katki, K. A. Articles by DiPette, D. J. Search for Related Content PubMed PubMed Citation Articles by Katki, K. A. Articles by DiPette, D. J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Related Collections Other hypertension Gene expression Hypertension - basic studies Other Vascular biology

(Hypertension. 2001;38:679.)
© 2001 American Heart Association, Inc.

Endocrine Systems

Role Of Calcitonin Gene-Related Peptide and Substance P in Dahl-Salt Hypertension

Khurshed A. Katki; Scott C. Supowit; Donald J. DiPette

From Department of Medicine, College of Human Medicine, Michigan State University, East Lansing.

Correspondence to Scott C. Supowit, PhD, Michigan State University, B-338 Clinical Center, East Lansing, MI 48824. E-mail scott.supowit{at}ht.msu.edu

Abstract

Abstract—— Calcitonin gene-related peptide (CGRP) and substance P are known to play a counterregulatory role in acquired models of salt-dependent hypertension. In contrast, neuronal production of these peptides is decreased in the spontaneously hypertensive rat, which may contribute to the elevated blood pressure. To determine the role played by CGRP and substance P in Dahl-salt hypertension, 4- to 6-week-old male salt-resistant (DR) and salt-sensitive (DS) rats were divided into 4 groups (n=5/group) and pair-fed low-salt (0.2% NaCl) (DR/LS and DS/LS) and high-salt (8% NaCl) diets (DR/HS and DS/HS) for 3 weeks. After 3 weeks, all the rats had venous (for drug administration) and arterial (for blood pressure monitoring) catheters surgically implanted and were studied in the conscious and unrestrained state. Mean arterial pressure was significantly higher in the DS/HS rats animals (185.8±1.6 mm Hg, P<0.001). Intravenous administration of CGRP and SP receptor antagonists was without effect in any of the groups studied. CGRP and SP mRNA content from dorsal root ganglia were not significantly different between the groups. Whereas immunoreactive CGRP was decreased in the DS groups (DS/HS, 9.4±0.4 pg/µg protein; DS/LS, 11.1±0.8 pg/µg protein; P<0.01) compared with the DR groups (DR/HS, 13.9±0.6 pg/µg protein; DR/LS, 14.6±0.6 pg/µg protein), neuronal SP production was similar between all the groups. Thus, CGRP and substance P do not play a counterregulatory role in Dahl-salt hypertension. The decrease in neuronal CGRP expression in DS rats appears to be genetically determined as in SHR, however, and may contribute to the increase in blood pressure following salt-loading.

Key Words: rats • neuropeptides • hypertension, genetic • blood pressure • RNA • radioimmunoassay

This article has been cited by other articles:

				J. Li and D. H. Wang Role of TRPV1 channels in renal haemodynamics and function in Dahl salt-sensitive hypertensive rats Exp Physiol, August 1, 2008; 93(8): 945 - 953. [Abstract] [Full Text] [PDF]

				Y. Wang and D. H. Wang A Novel Mechanism Contributing to Development of Dahl Salt-Sensitive Hypertension: Role of the Transient Receptor Potential Vanilloid Type 1 Hypertension, March 1, 2006; 47(3): 609 - 614. [Abstract] [Full Text] [PDF]

				Y. Wang, A. F. Chen, and D. H. Wang ETA receptor blockade prevents renal dysfunction in salt-sensitive hypertension induced by sensory denervation Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2005 - H2011. [Abstract] [Full Text] [PDF]

				Y. Wang and D. H. Wang Prevention of endothelin-1-induced increases in blood pressure: role of endogenous CGRP Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1868 - H1874. [Abstract] [Full Text] [PDF]

				K. A. Katki, S. C. Supowit, and D. J. DiPette Substance P in Subtotal Nephrectomy-Salt Hypertension Hypertension, February 1, 2002; 39(2): 389 - 393. [Abstract] [Full Text] [PDF]